Cover Image

Cost-utility and budget impact analysis for stopping the inappropriate use of proton pump inhibitors after cessation of NSAID or low-dose acetylsalicylic acid treatment

In accordance with current guidelines, proton pump inhibitors (PPIs) are now generally prescribed as a protective co-medication in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose acetylsalicylic acid (LDASA). However, less attention is paid to the corresponding discontinua...

Full description

Saved in:
Bibliographic Details
Main Authors: Chau, Sek Hung (Author) , Sluiter, Reinier Luuk (Author) , Hugtenburg, Jacqueline Geertruida (Author) , Wensing, Michel (Author) , Kievit, Wietske (Author) , Teichert, Martina (Author)
Format: Article (Journal)
Language:English
Published: 2020
In: Drugs & aging
Year: 2019, Volume: 37, Issue: 1, Pages: 67-74
ISSN:1179-1969
DOI:10.1007/s40266-019-00713-5
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s40266-019-00713-5
Get full text
Author Notes:Sek Hung Chau, Reinier Luuk Sluiter, Jacqueline Geertruida Hugtenburg, Michel Wensing, Wietske Kievit, Martina Teichert
Description
Summary:In accordance with current guidelines, proton pump inhibitors (PPIs) are now generally prescribed as a protective co-medication in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose acetylsalicylic acid (LDASA). However, less attention is paid to the corresponding discontinuation of a PPI after cessation of NSAID or LDASA treatment.
Item Description:Published online: 27 September 2019
Gesehen am 01.04.2020
Physical Description:Online Resource
ISSN:1179-1969
DOI:10.1007/s40266-019-00713-5

Similar Items